Bio-rad Laboratories, Inc. logo

BIO

Bio-rad Laboratories, Inc.

$304.15

Earnings Summary

Revenue
$610.82Mn
Net Profits
$383.92Mn
Net Profit Margins
62.85%

Highlights

Revenue:

Bio-rad Laboratories, Inc.’s revenue fell -9.75% since last year same period to $610.82Mn in the Q1 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated -10.33% fall in its revenue since last 3-months.

Net Profits:

Bio-rad Laboratories, Inc.’s net profit jumped 456.71% since last year same period to $383.92Mn in the Q1 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 9.78% jump in its net profits since last 3-months.

Net Profit Margins:

Bio-rad Laboratories, Inc.’s net profit margin jumped 516.88% since last year same period to 62.85% in the Q1 2024. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 22.43% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Bio-rad Laboratories, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
2
EPS Estimate Current Year
2

Highlights

EPS Estimate Current Quarter:

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2 - a -6.98% fall from last quarter’s estimates.

EPS Estimate Current Year:

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 2.

Key Ratios

Key ratios of the Bio-rad Laboratories, Inc. post its Q1 2024 earnings

Earning Per Share (EPS)
2.29
Return on Assets (ROA)
0.02
Return on Equity (ROE)
-0.03

Highlights

Earning Per Share (EPS):

Bio-rad Laboratories, Inc.’s earning per share (EPS) fell -31.44% since last year same period to 2.29 in the Q1 2024. This indicates that the Bio-rad Laboratories, Inc. has generated -31.44% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bio-rad Laboratories, Inc.’s return on assets (ROA) stands at 0.02.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bio-rad Laboratories, Inc.’s return on equity (ROE) stands at -0.03.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-08
2.15
2.29
6.51%

Discover More Earning Stocks in Health Technology Sector